Cubist Systematic Strategies’s Cymabay Therapeutics CBAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-62,516
Closed -$932K 4379
2023
Q3
$932K Buy
62,516
+10,771
+21% +$143K 0.01% 1925
2023
Q2
$567K Sell
51,745
-479,636
-90% -$4.47M 0.01% 2314
2023
Q1
$4.63M Buy
531,381
+478,052
+896% +$3.83M 0.04% 991
2022
Q4
$334K Sell
53,329
-112,916
-68% -$429K ﹤0.01% 3288
2022
Q3
$582K Buy
166,245
+114,911
+224% +$413K ﹤0.01% 3044
2022
Q2
$151K Buy
51,334
+17,654
+52% +$42.2K ﹤0.01% 3818
2022
Q1
$105K Buy
33,680
+9,189
+38% +$28.9K ﹤0.01% 3230
2021
Q4
$83K Buy
24,491
+5,778
+31% +$21.9K ﹤0.01% 3237
2021
Q3
$68K Sell
18,713
-44,987
-71% -$177K ﹤0.01% 2799
2021
Q2
$278K Sell
63,700
-87,740
-58% -$389K ﹤0.01% 2383
2021
Q1
$688K Buy
151,440
+73,861
+95% +$398K 0.01% 1776
2020
Q4
$445K Buy
77,579
+20,613
+36% +$156K 0.01% 1833
2020
Q3
$412K Buy
56,966
+41,130
+260% +$220K 0.01% 1856
2020
Q2
$55K Buy
15,836
+2,577
+19% +$7.44K ﹤0.01% 2264
2020
Q1
$20K Sell
13,259
-7,762
-37% -$13K ﹤0.01% 2065
2019
Q4
$41K Sell
21,021
-14,075
-40% -$52.9K ﹤0.01% 2294
2019
Q3
$180K Buy
35,096
+14,001
+66% +$84.8K ﹤0.01% 1814
2019
Q2
$151K Buy
+21,095
New +$239K ﹤0.01% 2154
2019
Q1
Sell
-26,897
Closed -$212K 2460
2018
Q4
$212K Buy
26,897
+20,099
+296% +$191K 0.01% 1495
2018
Q3
$75K Sell
6,798
-2,105
-24% -$26.1K ﹤0.01% 1648
2018
Q2
$119K Sell
8,903
-14,866
-63% -$186K 0.01% 1488
2018
Q1
$309K Buy
+23,769
New +$295K 0.02% 1126

Other funds holding CBAY